Erratum to: A retrospective study to identify risk factors for somnolence and dizziness in patients treated with pregabalin
نویسندگان
چکیده
[This corrects the article DOI: 10.1186/s40780-015-0022-7.].
منابع مشابه
A retrospective study to identify risk factors for somnolence and dizziness in patients treated with pregabalin.
BACKGROUND Pregabalin is a therapeutic drug for neuropathic pain that is associated with somnolence and dizziness. These adverse events are often experienced shortly after initiating pregabalin, and may lead to treatment discontinuation. The purpose of this study was to explore factors that influence the incidence of somnolence and dizziness induced by pregabalin, and to identify patients at hi...
متن کاملOpioid analgesics increase incidence of somnolence and dizziness as adverse effects of pregabalin: a retrospective study
BACKGROUND Pregabalin, a gabapentinoid, is an adjuvant analgesic for treatment of neuropathic pain, but it has serious adverse effects such as somnolence and dizziness, particularly in elderly patients. Although decreased renal function is considered to the contributing factor for high frequency of these adverse effects in elder patients, only a few systematic clinical investigations, especiall...
متن کاملFactors predicting adverse events associated with pregabalin administered for neuropathic pain relief
BACKGROUND Pregabalin administration is occasionally abandoned due to adverse events such as somnolence, dizziness, unsteadiness, weight gain and edema. However, the exact causes of these differences in adverse events associated with pregabalin have not been elucidated. OBJECTIVE To identify factors predicting adverse events associated with pregabalin administered for neuropathic pain. METH...
متن کاملA Comprehensive Drug Safety Evaluation of Pregabalin in Peripheral Neuropathic Pain
Pregabalin is a commonly used therapy currently recommended as first-line treatment for a number of neuropathic pain (NeP) conditions. Since licensure, a number of clinical trials of pregabalin in different NeP conditions have been completed from which additional data on safety and tolerability can be drawn. In this analysis, patient-level data from 31 randomized clinical trials of pregabalin i...
متن کاملCentral nervous system adverse effects of new antiepileptic drugs A meta-analysis of placebo-controlled studies
OBJECTIVE Systematic review and meta-analysis of the most frequent treatment-emergent central nervous system adverse events (CNS AEs) of new antiepileptic drugs (AEDs) from double-blind, add-on, placebo-controlled studies conducted in adult epileptic patients and identification of dose-adverse effect relationships. METHODS Trial reports found by searching Medline and journals. Outcome was the...
متن کامل